SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-001543
Filing Date
2024-01-18
Accepted
2024-01-18 18:02:56
Documents
1
Period of Report
2024-01-16

Document Format Files

Seq Description Document Type Size
1 form4-01182024_110149.html 4  
1 form4-01182024_110149.xml 4 3425
  Complete submission text file 0001415889-24-001543.txt   4894
Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Issuer) CIK: 0001426332 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O NGM BIOPHARMACEUTICALS, INC. 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Perlich Irene (Reporting) CIK: 0001989954 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38853 | Film No.: 24543159